ASX:IMR Imricor Medical Systems (IMR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Imricor Medical Systems Stock (ASX:IMR) 30 days 90 days 365 days Advanced Chart Get IMR alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27,486 shsAverage VolumeN/AMarket CapitalizationA$167.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota. Read More Receive IMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMR Stock News HeadlinesImricor Medical Systems Expands ASX Quotation with New SecuritiesSeptember 7 at 12:11 AM | tipranks.comImricor Advances U.S. Market Expansion with FDA SubmissionAugust 31, 2025 | tipranks.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone. | Porter & Company (Ad)Imricor Releases Shares from Voluntary Escrow, Boosting Market LiquidityAugust 28, 2025 | tipranks.comImricor Medical Systems Advances in Cardiac Ablation InnovationAugust 26, 2025 | msn.comImricor Medical Systems’ 1H 2025 Investor Presentation Highlights Global Expansion GoalsAugust 26, 2025 | msn.comHalf Year 2025 Imricor Medical Systems Inc Earnings Presentation TranscriptAugust 25, 2025 | gurufocus.comImricor Medical Systems to Announce FY25 1H ResultsAugust 15, 2025 | msn.comSee More Headlines IMR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imricor Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imricor Medical Systems investors own include Frequency Therapeutics (FREQ), Cue Biopharma (CUE), Provention Bio (PRVB), Gold Standard Ventures (GSV), Nuwellis (CHFS), BCB Bancorp, Inc. (NJ) (BCBP) and Atomera (ATOM). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryPharmaceutical Products Current SymbolASX:IMR CIKN/A Webwww.imricor.com Phone952-818-8400FaxN/AEmployees140Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$20.26 million Net Margins-2,458.31% Pretax MarginN/A Return on Equity266.83% Return on Assets-124.67% Debt Debt-to-Equity Ratio-146.38 Current Ratio1.46 Quick Ratio4.33 Sales & Book Value Annual SalesA$868.00 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow25.56 Book ValueA($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares270,180,000Free FloatN/AMarket CapA$167.29 million OptionableNot Optionable Beta0.26 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (ASX:IMR) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imricor Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imricor Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
